Curcumin as a Supportive Therapy in Type 2 Diabetic Patients

Type 2 diabetes mellitus (T2DM) is a growing public health concern. The management of diabetes is a lifelong process that requires diabetic education, attempts to achieve near optimal glycemic control, minimizing cardiovascular and other long-term risk factors, and avoidance of drugs that can exacer...

Full description

Saved in:
Bibliographic Details
Main Authors: Anand Seth (Author), Sravya Iyyuni (Author), Saurabh Sharma (Author), Ritu Sethi (Author), Suresh Nath (Author), Michael Imeokparia (Author)
Format: Book
Published: Hindawi Limited, 2024-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ecda6dcd496e47e2b2d34c67ee31d1ac
042 |a dc 
100 1 0 |a Anand Seth  |e author 
700 1 0 |a Sravya Iyyuni  |e author 
700 1 0 |a Saurabh Sharma  |e author 
700 1 0 |a Ritu Sethi  |e author 
700 1 0 |a Suresh Nath  |e author 
700 1 0 |a Michael Imeokparia  |e author 
245 0 0 |a Curcumin as a Supportive Therapy in Type 2 Diabetic Patients 
260 |b Hindawi Limited,   |c 2024-01-01T00:00:00Z. 
500 |a 2314-7784 
500 |a 10.1155/2024/8563066 
520 |a Type 2 diabetes mellitus (T2DM) is a growing public health concern. The management of diabetes is a lifelong process that requires diabetic education, attempts to achieve near optimal glycemic control, minimizing cardiovascular and other long-term risk factors, and avoidance of drugs that can exacerbate abnormalities of insulin and lipid metabolism. In the treatment of T2DM, curcumin has demonstrated much potential as an adjunct therapy due to its anti-inflammatory properties and its ability to reduce oxidative stresses within the body. However, the low bioavailability poses limitations to its therapeutic potential. In this paper, we discuss the benefits of curcumin in a healthy diet, its potential and limitations as a supportive therapy. The Ayurvedic perspective of curcumin in diabetes is also discussed. Mechanisms for increasing the bioavailability of the supplement is discussed. Also, epigenetic regulation of type 2 diabetes is discussed, especially the role of DNA methylation. 
546 |a EN 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Advances in Public Health, Vol 2024 (2024) 
787 0 |n http://dx.doi.org/10.1155/2024/8563066 
787 0 |n https://doaj.org/toc/2314-7784 
856 4 1 |u https://doaj.org/article/ecda6dcd496e47e2b2d34c67ee31d1ac  |z Connect to this object online.